Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation

Richland WA, Dec. 20, 2023 -- Vivos Inc. , Vivos Inc is pleased to announce that the Food and Drug Administration has granted RadioGel Precision Radionuclide Therapy the designation as a...

Related Keywords

Mike Korenko ,Michaelk Korenko ,Twitter ,Washington State University ,Breakthrough Devices Program ,University Of Missouri ,Vivos Inc ,Vivos Inc Vivosinc ,Globenewswire Inc ,Drug Administration ,Radiogel Precision Radionuclide Therapy ,Breakthrough Device ,Breakthrough Device Designation ,Risk Management Report ,Precision Radionuclide Therapy ,State University ,Veterinary Medicine ,Private Securities Litigation Reform Act ,Markets ,